United States· US:50268-321_48253893-9512-565b-e063-6294a90a8ad8

Flecainide Acetate

A flecainide product containing flecainide acetate, registered in United States by AvPAK. The same ATC class is registered in 18 of our 19 countries.

ATC C01BC04US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about flecainide acetateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Flecainide is registered in 18 of 19 countries.

Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
11 of them publish a price we can compare per daily dose

Search flecainide products by name

Flecainide · ATC C01BC04

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flecainide costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Flecainide · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

CH Switzerland$2.20
IT Italy$0.70
ES Spain$0.61
FR France$0.49

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: FLECAINIDE ACETATE
Manufacturer: AvPAK
Country: United States (US)
ATC code: C01BC04
ATC class: Flecainide
Defined daily dose: 0.2 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
50268-321-15
ndc11
5026832115
50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-321-15) / 1 TABLET in 1 BLISTER PACK (50268-321-11)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

342 interactions on record for flecainide.

Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check flecainide against other medicines How interaction checks work

Flecainide · interactions on record

342 records

42 severe
164 moderate
15 minor
75 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
EliglustatA16AX10severe

46 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flecainide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flecainide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Aristocor
Belgium · Apocard Retard, Flecainide Retard Eg
Bulgaria · Амаритон, Фелкарид
Cyprus · Flecardia
Czechia · Amarhyton, Amarhyton 100 Mg
Germany · Flecadura, Flecainid
Denmark · Flecainid Sandoz, Flecainid Stada
Spain · Apocard, Flecainida Aurovitas
Finland · Flecainide Orion, Tambocor
France · Flecaine, Flecaine L.P.
United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
Greece · Amarhyton, Flecainide/Flexmed
Croatia · Felkarid
Ireland · Flecainide Teva, Tambocor
Iceland · Flecainid Stada, Tambocor
Italy · Almarytm, Flecainide Aurobindo
Luxembourg · Apocard Retard, Flecainide Retard Eg
Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
Netherlands · Flecainide Acetate Aurobindo, Flecainide Acetate Ratiopharm
Norway · Flecainid Sandoz, Tambocor
Poland · Flecainide Acetate Holsten
Portugal · Amarhyton, Apocard
Romania · Amarhyton, Tambocor
Sweden · Tambocor, Tambocor Retard
Slovenia · Felkarid
Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cac4540c-1bee-4bf2-afff-73016dce2431
GET /v1/drugs/cac4540c-1bee-4bf2-afff-73016dce2431?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "100",
  "substance": "FLECAINIDE ACETATE",
  "productndc": "50268-321",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA075442",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about flecainide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console